DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We are enclosing herewith the schedule of earnings conference call for Q3FY23 to be held on February 03, 2023.25-01-2023
25-01-2023
DIVI'S LABORATORIES LTD. - 532488 - Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022.
DIVI''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2023 ,inter alia, to consider and approve the standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2022.23-01-2023
DIVI'S LABORATORIES LTD. - 532488 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we herewith submit certificate for the quarter ended December 31, 2022 received from M/s. KFin Technologies Limited, Registrar & Share Transfer Agent of the Company.07-01-2023
DIVI'S LABORATORIES LTD. - 532488 - Closure of Trading Window
Intimation of closure of Trading Window from January 01, 202324-12-2022
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Intimation of notice given to shareholders in respect of transfer of equity shares to IEPF Account by Newspaper advertisement24-12-2022
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
We hereby submit the transcript of the earnings conference call for the quarter and half year ended on September 30, 2022, held on November 07, 2022 at 14.00 Hrs IST. The transcript is also available on the website of the Company i.e. www.divislabs.com, under Investors Relations section.14-11-2022
DIVI'S LABORATORIES LTD. - 532488 - Submission Of Half Yearly Disclosure On Related Party Transactions For The Half Year Ended 30.09.2022
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we enclose disclosure of Related Party Transactions in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, for the half year ended September 30, 2022.14-11-2022
How much more can Divis Labs fall?
Is this a good time to buy shares of Divis Laboratories?11-11-2022
DIVI'S LABORATORIES LTD. - 532488 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India09-11-2022
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclose herewith copies of newspapers publication regarding extracts of unaudited financial results of the Company for the quarter and half year ended September 30, 2022. This was published on November 08, 2022 in Financial Express (English daily - All editions) and Andhra Prabha (Telugu daily - Hyderabad edition).08-11-2022